genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Parkinson's disease

Switching Gene Therapy On and Off with a Pill
Genome Editing

Switching Gene Therapy On and Off with a Pill

Neural Compass May Lead to Insights into Parkinson’s and Alzheimer’s Diseases
News

Neural Compass May Lead to Insights into Parkinson’s and Alzheimer’s Diseases

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?
Drug Discovery

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?

Gene Variants Linked to Parkinson’s Disease after Long-Term Pesticide Exposure
Featured

Gene Variants Linked to Parkinson’s Disease after Long-Term Pesticide Exposure

“Tissue-in-a-CUBE” System Models Blood-Brain Barrier
Drug Discovery

“Tissue-in-a-CUBE” System Models Blood-Brain Barrier

RiboTAC Targets “Undruggable” Parkinson’s Protein, α-Synuclein
Drug Discovery

RiboTAC Targets “Undruggable” Parkinson’s Protein, α-Synuclein

Novel Insights into Protein Aggregation in Parkinson’s Disease Revealed
News

Novel Insights into Protein Aggregation in Parkinson’s Disease Revealed

How Subsecond Changes in Brain Dopamine Levels Impact Human Behavior
Featured

How Subsecond Changes in Brain Dopamine Levels Impact Human Behavior

Nanoplastics-Brain Protein Interaction Creates Changes Linked to Parkinson’s Disease
Featured

Nanoplastics-Brain Protein Interaction Creates Changes Linked to Parkinson’s Disease

Gene Variant Linked to New Forms of Early-Onset Dystonia, Parkinsonism
News

Gene Variant Linked to New Forms of Early-Onset Dystonia, Parkinsonism

1234Page 1 of 4

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up